Filing Details
- Accession Number:
- 0001209191-13-046858
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-02 20:15:04
- Reporting Period:
- 2013-09-30
- Filing Date:
- 2013-10-02
- Accepted Time:
- 2013-10-02 20:15:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-30 | 6,441,819 | $0.00 | 6,441,819 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-09-30 | 455,000 | $22.00 | 6,896,819 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A PREFERRED STOCK | Disposition | 2013-09-30 | 14,374,443 | $0.00 | 2,806,937 | $0.00 |
| Common Stock | SERIES B PREFERRED STOCK | Disposition | 2013-09-30 | 5,208,334 | $0.00 | 995,520 | $0.00 |
| Common Stock | SERIES C PREFERRED STOCK | Disposition | 2013-09-30 | 15,438,009 | $0.00 | 2,639,359 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Series A, B and C Preferred Stock (collectively, the "Preferred Stock") has no expiration date and was converted upon the closing of the Issuer's initial public offering (the "IPO Closing") on a one-for-5.9000 basis, as adjusted to give effect to the reverse stock split of the Issuer's Common Stock at the IPO Closing.
- Includes three (3) shares received as a result of the aggregation of fractional shares at the time of conversion and stock split.
- Includes 370,591 shares of Common Stock issuable upon conversion as dividends that accrued on each series of Preferred Stock prior to conversion.
- Includes 112,752 shares of Common Stock issuable upon conversion as dividends that accrued on each series of Preferred Stock prior to conversion.
- Includes 22,748 shares of Common Stock issuable upon conversion as dividends that accrued on each series of Preferred Stock prior to conversion.
Billionaire Hedge Funds
